In another study, Chen et al. found that trifluoperazine enhances the chemotherapeutic effect of doxorubicin in doxorubicin-resistant SHG44/DOX glioma cell lines by stimulating Forkhead box O1 (FOXO1) nuclear translocation. The gene discussed is FOXO1; the disease is central nervous system cancer.